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developing a Decision Analytic Model to plan
services for sexually transmitted infections in
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Catherine R H Aicken1, Nigel T Armstrong2, Jackie A Cassell1,3, Neil Macdonald4, Angela C Bailey5,
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Background: Decision Analytic Models (DAMs) are established means of evidence-synthesis to differentiate
between health interventions. They have mainly been used to inform clinical decisions and health technology
assessment at the national level, yet could also inform local health service planning. For this, a DAM must take into
account the needs of the local population, but also the needs of those planning its services.
Drawing on our experiences from stakeholder consultations, where we presented the potential utility of a DAM for
planning local health services for sexually transmitted infections (STIs) in the UK, and the evidence it could use to
inform decisions regarding different combinations of service provision, in terms of their costs, cost-effectiveness,
and public health outcomes, we discuss the barriers perceived by stakeholders to the use of DAMs to inform
service planning for local populations, including (1) a tension between individual and population perspectives;
(2) reductionism; and (3) a lack of transparency regarding models, their assumptions, and the motivations of those
generating models.
Discussion: Technological advances, including improvements in computing capability, are facilitating the
development and use of models such as DAMs for health service planning. However, given the current scepticism
among many stakeholders, encouraging informed critique and promoting trust in models to aid health service
planning is vital, for example by making available and explicit the methods and assumptions underlying each
model, associated limitations, and the process of validation. This can be achieved by consultation and training with
the intended users, and by allowing access to the workings of the models, and their underlying assumptions
(e.g. via the internet), to show how they actually work.
Summary: Constructive discussion and education will help build a consensus on the purposes of STI services, the
need for service planning to be evidence-based, and the potential for mathematical tools like DAMs to facilitate
this.
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Health services consist of collections of complex clinical
pathways for many patients, and as such, are challenging
to plan. Compared to service delivery for individual
patients, for which evidence-based approaches are well-
established [1], there is less of a tradition of evidence-
based service planning. For example, evidence-based
guidelines exist for treating an individual presenting with
certain symptoms, but it is unclear how to plan appro-
priate combinations of services to meet the varying
needs of local populations. Even individual clinical ser-
vices, such as hospitals, are often planned on the basis
of limited evidence and without making assumptions ex-
plicit [2]. Planning services for infectious diseases, in-
cluding sexually transmitted infections (STIs), is still
more complex, since each case may or may not produce
further cases [3], such that the goals of early detection
and treatment are not only to improve the health of the
individual but that of the wider population too [4].
Currently, evidence-based STI service planning for lo-
calities may begin with a sexual health needs assessment
of the local population, typically involving collation and/
or collection of (largely) quantitative data, and expert
opinion, together with descriptions (or mapping) of
current provision [5]. However, seldom is this informa-
tion then used explicitly or directly to inform the vol-
ume of different types of services that should be
provided to meet the population’s needs, often because
service planners are unclear as to how this can be done
[6]. Yet various tools have been used to help policy-
makers choose between health technologies, and these
could be developed to assist service planning in this
health area. Decision Analytic Models (DAMs) are one
type of tool and are well-established in Cost Effective-
ness Analysis (CEA) [7] as part of Health Technology
Assessment [7-10].
A DAM is a mathematical method of synthesising evi-
dence on the outcomes and costs of alternative, mutually
exclusive, healthcare interventions [10]. As an example,
a simple generic DAM could be one that combined evi-
dence on resource use (e.g. staff time) with price infor-
mation (e.g. salary) to show the costs of each of the
alternatives available to a decision-maker. A DAM ap-
plied to service delivery would need a more complex
structure as it needs to take account of the costs of
current and/or planned service provision, the features of
these service provision alternatives (e.g. the numbers
and characteristics of patients attending the different
types of services in the locality), along with indicators of
population need (e.g. demographic characteristics, dis-
ease prevalence) for public health outcomes, such as the
incidence of disease. While such models are computa-
tionally demanding, increases in computing power are
facilitating the consideration of such complexities.The synthesis of different types of data is an attractive
feature of a DAM, although it is important to recognise
that DAMs do not act as a substitute for the best avail-
able evidence, and as a model, a DAM is only as good as
the data it synthesises. Other attractive features include
that a DAM’s inputs, assumptions, and model structure
can all be made explicit [11], and the results of sensitiv-
ity analyses (the effect on outcomes of changes in input
parameters [12,13]), can be published, revealing how the
model works and how robust it is.
The MSTIC study, an abbreviation for ‘Maximising
STI Control in local populations’, funded by the UK
Medical Research Council (grant number G0601685)
sought to develop a DAM to be used by planners of
local STI services. Specifically, we aimed to develop a
tool to compare the impacts of different combinations of
specialist, genitourinary medicine (GUM) services and
primary-care based services, on STI incidence and the
associated costs and cost-effectiveness. The DAM was to
be based on a model of STI transmission that took into
account demographic characteristics, for example, the
age-sex structure of a local population [13].
We assumed that users of the DAM would not have
specialist knowledge of health economics or epidemio-
logical modelling so we planned to present the results of
the DAM as an interactive web-based tool. While several
health-related web-tools are publicly available and in use
(e.g. QRISKW2 [14]), they are novel in service planning
[15]. We recognised that our web-tool should not re-
quire a high level of computing expertise or a steep
learning-curve for its use, and so we planned that users
would simply input data for their locality into the tool,
with online help resources available. The web-tool would
process these data using the results of the underlying
model to generate outputs. By varying the data entered
for different parameters, users could view the epidemio-
logical and economic implications of changing, for ex-
ample, the overall capacity or relative capacities of
specialist and primary-care based services. We planned
to include a technical appendix in the web-tool’s user
guide that stated all the assumptions and parameter esti-
mates used in the underlying DAM to promote transpar-
ency and, we hoped, trust in the web-tool.
To explore the extent to which our DAM, presented
as a web-tool, would be considered by stakeholders as a
useful and acceptable adjunct to service planning, we
sought the views of service providers, public health spe-
cialists and commissioners working in sexual health. We
presented our research plans for developing a DAM and
web-based tool to assist the planning of STI services for
local populations, as described above, to a workshop on
the sources and uses of sexual health data, held in
March 2009, comprising approximately 80 clinicians,
public health specialists and commissioners, all with a
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STI services in one region of England. Data collection
was by means of notes taken during a plenary discus-
sion, and we solicited stakeholders’ views by inviting the
participants to discuss the tool with us after the discus-
sion (face-to-face or by email after the event), and
provided sticky notes to be stuck onto a flip-chart –
conduits for public and more private feedback. In this
paper, we describe the themes that emerged rather than
present direct quotations, as we did not request partici-
pants’ permission to quote them, nor did we record the
workshop.
Here we present the major themes expressed that were
of interest and concern for the stakeholders. We then
discuss implications for the development, dissemination
and potential use of DAMs in the planning of local
health services.
Discussion
First we present reactions emerging from our initial
presentation of our research plans. We then discuss pos-
sible reasons for these, and considerations for others
attempting similar work in this area.
Reactions and responses to the concept of a DAM for STI
service planning
Views expressed in the plenary were generally sceptical
about the relevance and utility of a DAM for STI service-
planning. However, following this discussion several indi-
viduals privately expressed support for our proposed
DAM and web-tool and offered constructive feedback.
Three key themes emerged from the workshop:
1) Tension between the individual and population
perspectives
A number of stakeholders expressed a focus on the
individual patient’s health benefit, and more
generally the patient’s healthcare experience, almost
to the exclusion of wider public health benefit that
services might provide, i.e. their impact upon rates
of infection. As such, some interpreted the MSTIC
study’s objective as directly opposed to providing
‘holistic’ patient-centred care, and criticised the
DAM’s lack of assessment of more qualitative
aspects of healthcare provision because of its focus
solely on quantifiable inputs and outputs. Given this
perceived conflict between the individual and
population perspectives, it was unsurprising that
some stakeholders were wary of cost-effectiveness
evidence as well as health economics more generally.
2) Reductionism
The proposed DAM was criticised for being
‘reductionist’, and some stakeholders argued that it
overlooked the complexity of service provision andthe ‘real world’. For example, some felt that the
DAM’s consideration of the different types of STI
service that may be available in a locality was over-
simplified and that it did not capture the variability
in service provision, for instance between different
GUM clinics and between different general
practices.
The ‘reductionist’ criticism also applied to the
DAM’s inputs and outputs. In our presentation, we
explained that in a DAM’s development, inputs can
be varied within realistic ranges in order to
determine which are most influential on the outputs
(sensitivity analyses) [11,12] and conversely which
data inputs are relatively unimportant and so need
not be collected. We thought that the volume of
information service planners can reasonably be
expected to gather, as well as the ease with which
they can do so, would be important considerations.
Consequently, we perceived the reduced burden of
data collation associated with using a DAM as an
attractive feature. However, a number of the
audience interpreted the concept of making
decisions based on a reduced set of variables as less
evidence-based. Indeed, some participants later in
the event called for more data collection to inform
improved service planning.
3) Lack of transparency
Formulation of a DAM involves building a structure
that synthesises key inputs, which, as we explained
to the audience, we planned to present as an
interactive web-tool to make the DAM easily
accessible. We perceived this as an additional
strength of our model. However, our audience was
concerned that the DAM would be a ‘black box’ and
called for the model’s workings not to be concealed.
Our perceived motives for developing a DAM to
assist in STI service planning were also a source of
criticism. For example, our plan to incorporate cost-
effectiveness evidence into our model was viewed by
some as an underhand threat of service cuts, or as
providing evidence that could be exploited either for
that purpose or to redistribute resources between
services. However, we observed a public/private split
in expressed attitudes to the proposed DAM, as
several participants approached us privately later in
the event expressing support for the use of health
economic methods in service planning and engaged
in discussion about the assumptions a DAM could
reasonably make.
Why are quantitative, model-based tools for service
planning helpful? And why are they not more popular?
The increasing diversity of health services providing care
for STIs in the UK [16], together with the dynamic
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portant to assess the impact of different combinations of
service provision with varying clinical outcomes on STI
control in local populations. While tools based on such
quantitative evidence can be used to make explicit com-
parisons between service configurations for a locality,
our consultation found that tools like a DAM may be
perceived as threatening and reductionist by clinicians,
local public health staff and service commissioners. This
may reflect epistemological differences in the ways in
which we, as academic researchers, and our stakeholders
approach STI service planning, including what constitu-
tes valid evidence, and how this evidence should be
brought together. An example of this difference was the
particular tension we observed between the individual
and public health perspectives, reflecting the differing
goals of the clinician and public health advocate [17].
Another example is a misunderstanding of the use of
health economics, as others have discussed [18], which
may in part reflect cynicism in the way the language of
economics is perceived to be used by public figures
attempting to justify cost-cutting, and not simply a lack
of understanding of the discipline.
Lack of understanding of models may contribute to
health professionals’ reluctance to follow their recom-
mendations [19], and this can apply to DAMs as well as
other mathematical models. Furthermore, where a tool
originates outside a user’s discipline, and he or she may
not know (or trust) the interests of those who created
and funded the model, this can also contribute to mis-
trust in the results [20]. Yearley [20] reported that public
understanding of computerised scientific models
depends on the trustworthiness of the institutions devel-
oping models, the public’s own knowledge (and lack of
recognition by scientists of this), and the evaluation of
assumptions within models (which may indeed not be
appropriate), which can override the credibility and ap-
peal that models might otherwise have. As publicly-
funded scientists working on the MSTIC study, we must
clearly emphasise to potential users of our web-tool that
we have no stake in the cutting or funding of particular
types of service – but it remains unclear how much re-
assurance our separation from decision-making will give.
As noted above, assumptions made and data used by a
DAM can limit its validity – yet these potential limita-
tions can apply to other methods for planning services
too. Where DAMs (and other mathematical models)
contain parameters which are poorly understood and
therefore particularly uncertain, for example, transmis-
sion probabilities, then different models of the same out-
come can result in very different predictions, as was the
case with predicting the population impact of chlamydia
screening [9,21-23]. Together with the media’s coverage
of models that have been less successful in theirpredictions (e.g. climate change modelling, swine flu
modelling) [24,25], this is likely to exacerbate health pro-
fessionals’, and more generally, the public’s mistrust in
the validity and utility of modelling. Further robust val-
idation of tools such as DAMs for service planning, in
any case a valuable exercise, may enable us to advocate
more confidently their use in this area, and perhaps allay
some of the scepticism of clinicians and commissioners.
Nevertheless, among those whose reservations about
DAMs for service planning are more fundamental (mis-
trust in health economics and/or a quantitative approach
to planning, for example), it is unclear whether further
validation will be convincing.
We note that DAMs do not constitute ‘research evi-
dence’ in the empiricist tradition (such as the results of
randomised controlled trials or service evaluations). Nei-
ther do they ‘fit’ within a conventional step in the commis-
sioning cycle [26]. Unsurprisingly, the UK’s National
Institute for Health and Clinical Excellence (NICE) has
produced guidance informing the commissioning of ser-
vices for various types of cancer [27], but not for STIs or
indeed any infectious diseases. The potential role of
DAMs is, as we have seen, untested and their use under-
developed at the present time and, as discussed earlier, less
straightforward for infectious diseases. The relative nov-
elty of using models for STI service planning may there-
fore have made it difficult for stakeholders to engage with,
and discuss, our proposed DAM and web-tool.
There is however a clear need to improve evidence-
based service planning as current efforts involve colla-
tion (and often collection) of a considerable amount of
data, combined in ways which may be neither transpar-
ent nor, in effect, any less reductionist. This is not only
time-consuming but there is also evidence of a large du-
plication of work between those planning services for
different localities in the same health areas [28]. It was
therefore interesting to see that our proposal to use a
DAM, which would reduce the amount of data required
for evidence-based planning by identifying only key
parameters, was unfavourably received in our consult-
ation. On the contrary, there were calls for more data
collection rather than evidence-based methods of using
existing data.
The difference we observed between publicly and pri-
vately expressed views on the DAM is telling, and may
reflect tensions between roles, particularly between clini-
cians and those in managerial/planning roles [29]. While
ultimately it is commissioners of local services, within
budgetary and other constraints, who must decide which
combination of services to fund [28], there is a need to
acknowledge the objectives, expertise and role that clini-
cians and public health leads play. This though can cre-
ate conflict when commissioners consult local experts in
sexual health while also considering cutting or
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sons of cost-effectiveness when assessing the public
health impact of services, for example, through using a
DAM, may raise awkward questions to the different par-
ties in these collaborations, particularly around funding
allocation. Central to evidence-based planning of service
delivery is therefore the creation and nurturing of mean-
ingful dialogue among clinicians and managers [30], to-
gether with commissioners. This will be increasingly
important given changes to the commissioning of health
services specified in the Liberating the NHS White Paper
[31], as well as in the context of public spending cuts.Summary
It is apparent that there is a need for more and better
dialogue between health professionals on the one hand,
and epidemiologists and health economists on the other,
to improve understanding of the benefits and limitations
of mathematical decision-making tools such as DAMs.
For example, while our approach was perceived by some
stakeholders as reductionist, the fact needs to be con-
veyed that all service planning methods make simplifica-
tions and assumptions, and are reliant on the accuracy
of the available data. Simplifications are not always justi-
fied or even made explicit, so that detailed critique and
discussion is lacking. Ongoing consultation is therefore
essential for the development and implementation of
novel technology and methods. With an increasing em-
phasis in publicly funded research on how research feeds
into public policy and practice [32], this is an important
skill for public health researchers to develop.
Of equal importance is the need for continued learning
among clinicians and decision-makers regarding the na-
ture and value of evidence and methods from different dis-
ciplines. Researchers can clearly play a part in this as well,
for example, by using innovative methods for explaining
health economic methods and cost-effectiveness (e.g.
Democs [33]), and not only by demonstrating the validity
of DAMs for service planning but by communicating how
validation has been undertaken. We also believe that
allowing users easier access, such as through our web-tool,
is vital if DAMs are to be transparent. Thus, constructive
discussion and education will help build a consensus on
the purposes of STI services, the need for service planning
to be evidence-based, and the potential for mathematical
tools like DAMs to facilitate this.Abbreviations
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